CD4 and glioblastoma: Principal Component Analysis (PCA) and Hierarchical Cluster Analysis (HCA) of CpG methylation showed distinct variability between blood and tumor CD4+ T cells of GBM patients with no significant interpersonal variability in the CD4+ T cells from the blood but significant individual variability in the CD4+ T cells from the tumor (Figure 1F and 1G, respectively).